کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
2552023 | 1560694 | 2010 | 7 صفحه PDF | دانلود رایگان |

AimsTo establish the differential cytoprotective activity against arsenic (As) toxicity of the flavonoids silymarin (S), which is without protective effects on cancer cells, and quercetin (Q). Arsenic (As) has a paradoxical biomedical role: it causes oxidative damage to normal cells leading to death or malignant transformation, but can be used, for the same reason, as an anticancer pro-apoptotic agent at high doses.Main methodsAqueous hydroperoxides (AHP), JNK (c-Jun N-terminal kinase) activation, caspase activity and death phenotype were assessed in CHO-K1 cells treated with As, S, Q, As + S and As + Q (p < 0.05).Key findingsQ proved to be toxic and did not exert complete protection against As, and only S was able to protect cells from As-induced oxidative death, which started after 4 h with caspase activation and phosphatidylserine exteriorization on the outer cellular membrane. Although both flavonoids counteracted As-induced JNK activation (an early stress response, i.e. exposure biomarker), AHP were increased by As and Q (p < 0.05). Moreover, Q-treated cells triggered per se apoptosis and even necrosis. Also, the classical sequence oxidative stress-JNK activation-cell death was seen for As, but not for Q, with S stopping the sequence.SignificanceThese results strongly suggest that the use of silymarin increases the possibility of designing better arsenic-based cancer chemotherapies with less toxicity to normal cells.
Journal: Life Sciences - Volume 87, Issues 9–10, 28 August 2010, Pages 309–315